Home » Stocks » Fonar Corporation

Fonar Corporation (FONR)

Stock Price: $25.81 USD 0.80 (3.20%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 176.30M
Revenue (ttm) 87.37M
Net Income (ttm) 12.25M
Shares Out 6.45M
EPS (ttm) 1.76
PE Ratio 14.66
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $25.81
Previous Close $25.01
Change ($) 0.80
Change (%) 3.20%
Day's Open 25.00
Day's Range 24.73 - 26.00
Day's Volume 41,325
52-Week Range 11.00 - 26.00

More Stats

Market Cap 176.30M
Enterprise Value 173.41M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 6.45M
Float 5.80M
EPS (basic) 1.8
EPS (diluted) 1.76
FCF / Share 1.96
Dividend n/a
Dividend Yield n/a
Earnings Yield 6.82%
FCF Yield 7.58%
Payout Ratio n/a
Shares Short 183,835
Short Ratio 2.30
Short % of Float 3.33%
Beta 1.13
PE Ratio 14.66
Forward PE n/a
P/FCF Ratio 13.19
PS Ratio 2.02
PB Ratio 1.31
Revenue 87.37M
Operating Income 17.13M
Net Income 12.25M
Free Cash Flow 13.36M
Net Cash 2.89M
Net Cash / Share 0.42
Gross Margin 49.46%
Operating Margin 19.61%
Profit Margin 13.20%
FCF Margin 15.29%
ROA 7.19%
ROE 13.85%
ROIC 9.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue87.1981.5278.0473.3769.0568.5149.1439.4433.1431.82
Revenue Growth6.96%4.46%6.36%6.25%0.8%39.4%24.58%19.04%4.15%-
Gross Profit43.2139.5739.9834.5032.1632.6523.0218.2514.6613.20
Operating Income22.1319.6819.1014.3612.9012.307.547.213.79-2.58
Net Income15.3221.2319.6215.7212.9110.408.685.783.16-3.01
Shares Outstanding6.356.296.166.056.056.015.936.165.654.93
Earnings Per Share2.223.102.922.381.951.581.340.910.55-0.61
EPS Growth-28.39%6.16%22.69%22.05%23.42%17.91%47.25%65.45%--
Operating Cash Flow19.4518.7416.8116.6213.2713.397.547.413.15-1.50
Capital Expenditures-3.36-2.78-2.85-0.71-0.13-0.62-1.14-1.08-0.60-0.23
Free Cash Flow16.0915.9613.9615.9113.1412.776.406.332.55-1.73
Cash & Equivalents28.9819.6310.148.539.459.957.8712.039.371.68
Total Debt0.310.340.524.518.1911.3715.772.633.772.31
Net Cash / Debt28.6619.299.624.021.26-1.42-7.909.405.59-0.62
Assets13411898.7684.8976.4976.7973.1533.6431.5821.63
Liabilities15.4516.0815.8524.1125.7130.8835.3522.5325.7127.40
Book Value11698.6877.4452.3838.3925.3114.115.005.87-5.78
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Fonar Corporation
Country United States
Employees 500
CEO Timothy R. Damadian

Stock Information

Ticker Symbol FONR
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: FONR
IPO Date January 1, 1987

Description

FONAR Corporation, together with its subsidiaries, operates as a magnetic resonance imaging (MRI) company primarily in the United States. It is involved in the research, development, production, and marketing of medical scanning equipment, which uses principles of MRI for the detection and diagnosis of human diseases. The company operates in two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 4 diagnostic imaging facilities in Florida; and manages 25 MRI scanning facilities, including 18 facilities located in New York and 7 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was founded in 1978 and is based in Melville, New York.